Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
VR-CHOP regimen
Introduction
Overview
Overview
VR-CHOP regimen refers to a regimen consisting of velcade (bortezomib), rituximab, cyclophosphamide, hydroxydaunorubicin (doxorubicin), oncovin (Vincristine), prednisone used to treat previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.[1] .
Regimen
Regimen
VVelcade (Bortezomib)
RRituximab
CCyclophosphamide
HHydroxydaunorubicin (Doxorubicin)
OOncovin (Vincristine)
PPrednisone
References
References
- ↑ 1.0 1.1 Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM; et al. (2011). “Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma”. J Clin Oncol. 29 (6): 690–7. doi:10.1200/JCO.2010.31.1142. PMID 21189393.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]